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Does It Matter Where You Go for Breast Surgery?
Attending Surgeon’s Influence on Variation in Receipt of Mastectomy
for Breast Cancer
Steven J. Katz, MD, MPH,*† Sarah T. Hawley, PhD, MPH,*‡ Paul Abrahamse, MA,*
Monica Morrow, MD,§ Christopher R. Friese, RN, PhD, AOCN,¶ Amy K. Alderman, MD,
Jennifer J. Griggs, MD, MPH,** Ann S. Hamilton, PhD, MA,†† John J. Graff, PhD, MS,‡‡
and Timothy P. Hofer, MD, MSc*‡
Background: Concerns about the use of mastectomy and breast
reconstruction for breast cancer have motivated interest in surgeon’s
influence on the variation in receipt of these procedures.
Objectives: To evaluate the influence of surgeons on variations in
the receipt of mastectomy and breast reconstruction for patients
recently diagnosed with breast cancer.
Methods: Attending surgeons (n  419) of a population-based
sample of breast cancer patients diagnosed in Detroit and Los
Angeles during June 2005 to February 2007 (n  2290) were
surveyed. Respondent surgeons (n  291) and patients (n  1780)
were linked. Random-effects models examined the amount of vari-
ation due to surgeon for surgical treatment. Covariates included
patient clinical and demographic factors and surgeon demographics,
breast cancer specialization, patient management process measures,
and attitudes about treatment.
Results: Surgeons explained a modest amount of the variation in
receipt of mastectomy (4%) after controlling for patient clinical and
sociodemographic factors but a greater amount for reconstruction
(16%). Variation in treatment rates across surgeons for a common
patient case was much wider for reconstruction (median, 29%;
5th–95th percentile, 9%–65%) then for mastectomy (median, 18%;
5th–95th percentile, 8% and 35%). Surgeon factors did not explain
between-surgeon variation in receipt of treatment. For reconstruc-
tion, 1 surgeon factor (tendency to discuss treatment plans with a
plastic surgeon prior to surgery) explained a substantial amount of
the between-surgeon variation (31%).
Conclusion: Surgeons have largely adopted a consistent approach to
the initial surgery options. By contrast, the wider between-surgeon
variation in receipt of breast reconstruction suggests more variation
in how these decisions are made in clinical practice.
Key Words: surgeons, breast cancer, treatment variation
(Med Care 2010;48: 892–899)
The appropriateness in rates of mastectomy for treatment ofbreast cancer has been a contentious policy issue for over
2 decades. There are lingering concerns that surgeons are
recommending overly aggressive care, given persistently
high rates of mastectomy and wide regional variation despite
strong professional consensus favoring less invasive treat-
ment.1–3 However, recent studies suggest that surgical treat-
ment decisions are a result of a more complex interplay
between surgeon recommendations and patient prefere-
nces.2,4,5 Breast reconstruction following mastectomy has
also been a focus of policy concerns because low rates of use
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and sociodemographic disparities suggest potentially that
there is underuse in some groups.6,7
These issues motivate interest in quantifying attending
surgeon’s influence on the variation in receipt of surgical
treatment for breast cancer. Surgeons have a primary role in
decisions about breast cancer treatment options, including
postmastectomy reconstruction,2,7 and there are large differ-
ences in surgeon specialization and practice context.8 In prior
work, we found that the individual surgeon explained a
moderate amount of the variation in mastectomy rates (7.5%)
and larger amount of the variation in reconstruction rates
following mastectomy (15%) after controlling for patient
clinical and demographic characteristics.9
The present study advances the research in a new, more
recently diagnosed, population-based cohort of patients by
addressing 2 questions motivated by the prior findings.9 First,
are there patient factors beyond those originally studied that
might further explain surgeon variation in receipt of treat-
ment? Some women, as part of their primary treatment, have
a mastectomy that follows very soon after BCS, which is
clearly a different decision than the earlier initial decision for
BCS versus mastectomy. Additionally, some women have
contraindications to breast conserving surgery (BCS) due to
characteristics not readily available in the Surveillance, Epi-
demiology, and End Result (SEER) data. Our earlier research
could not evaluate whether the differential distribution of
these attributes might contribute to the variation attributed to
the surgeon. Finally, the earlier study oversampled patients
with ductal carcinoma in situ (DCIS) cancer by design and,
thus, may not have reflected the amount of surgeon variation
seen in patients presenting with a population spectrum of
breast cancer.
The second question is whether certain features of
surgical practices, endorsed in a recent Institute of Medicine
report and promoted by national organizations as key ele-
ments of quality cancer care,10–13 may explain some degree
of the surgeon level variation.8 Because there are no existing
measures of these constructs in delivery of cancer care, we
developed and evaluated our own measures of patient man-
agement process factors, using the Chronic Care Model.8 A
unique feature of the present study is our ability to evaluate
the degree to which such practice factors contribute to sur-
geon variation in breast cancer treatments.
METHODS
Study Sample
Details of the patient study have been published else-
where.14–17 We enrolled a population-based sample of 3133
women in the metropolitan areas of Los Angeles and Detroit,
aged 20 to 79 years recently diagnosed with breast cancer
during a period from June 2005 through February 2007. We
excluded patients with Stage 4 breast cancer, those who died
prior to the survey, those who could not complete a question-
naire in English or Spanish, and Asian women in Los Angeles
(because of enrollment in other studies). Latinas (in Los
Angeles) and African-Americans (in both Los Angeles and
Detroit) were over-sampled. Eligible patients were identified
from the SEER program registries of both regions. The
Dillman survey method was employed to encourage survey
response.18 Patients completed a survey approximately 9
months after diagnosis (96.5% by mail and 3.5% by phone),
and this information was merged to SEER clinical data. The
response rate was 73.1% (n  2290) of whom 2268 patients
(72.4%) had complete SEER data. The study was approved
by the Institutional Review Boards of the University of
Michigan, University of Southern California, and Wayne
State University.
An attending surgeon was identified for 98.9% of the
patient sample using information from patient reports, pathol-
ogy reports, and SEER. Surgeons were mailed a letter of
introduction, a survey, and a $40 subject fee approximately
14 months after the start of patient survey. We used a
modified version of the Dillman method to optimize re-
sponse.18 We identified 419 surgeons, of whom 318 returned
completed questionnaires (response rate, 75.9%). The patient
and surgeon records were merged to create an analytic dataset
with 1780 respondent patients (56.8% of eligible patients)




We used 2 dependent variables derived from the patient
survey: (1) the first surgical treatment (mastectomy vs. BCS
with or without radiation) was determined by asking women
what was the first surgery performed after biopsy; and (2)
receipt of postmastectomy reconstruction defined as women
who responded that they received breast reconstruction be-
fore being surveyed (yes vs. no).
Patient-Related Independent Variables
Clinical variables (derived from SEER) included tumor
size (1 cm, 1–2 cm, 2–5 cm, 5 cm, and missing); histo-
logic grade (well-differentiated, moderately differentiated,
poorly differentiated, undifferentiated, missing); and tumor
behavior (DCIS vs. invasive) because this information is
generally available to surgeons at the time of surgery consul-
tation. Patient demographics included age (categorical), race/
ethnicity (white, black, Latina, other), education (high school
graduate or less vs. some college or more), marital status
(married/partnered, not married), and SEER site. Patient
report of a clinical contraindication to BCS (yes/no) was
measured based on a list of reasons her surgeon recom-
mended mastectomy (eg, the tumor was too large or too
diffusely located in the breast or that the initial surgery did
not get it all).2,19
Surgeon-Related Independent Variables
We evaluated 3 sets of independent variables related to
surgeons: (1) demographics; (2) level of breast cancer prac-
tice specialization; and (3) patient management factors. De-
mographic factors included surgeon gender and number of
years in practice after training (continuous). Level of breast
cancer specialization was measured by surgeon report of the
percentage of total practice devoted to breast cancer (15%,
15%–49%, and 50%). To measure patient and practice
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management process factors, we developed 5 scales reflecting
implementation of a coordinated cancer care model in a
surgical practice. The distribution of these measures in sur-
gical practices has been recently described.8 These are com-
prised of patient and practice management processes reported
by the surgeons. Of these 5, 3 had a monotonic relationship
with mastectomy and reconstruction in bivariate analyses,
and were included in the analysis. These included first, a
Multidisciplinary Communication scale based on 3 items for
which surgeons indicated the share of their patients in the
prior year for whom they discussed a treatment plan with a
medical oncologist, radiation oncologist, or plastic surgeon
prior to surgery. Second, an Availability of Clinical Informa-
tion scale was based on 3 items where surgeons indicated the
share of their patients in the prior year who came for a second
opinion whom they (1) had specimens that were collected by
another; provider reviewed again by your pathologist; (2) had
mammogram images that were taken at another institution
reviewed again by your radiologist; (3) repeated mammo-
gram images that were brought from another institution. And
third, a Patient Decision and Care support scale was based on
5 items where surgeons indicated the share of their patients
who (1) attended a presentation about breast cancer organized
by your practice; (2) viewed video about treatment issues
made available through your practice; (3) were referred to
website tailored to your practice; (4) attended a patient
support group organized by your practice; or (5) talked to
other patients arranged by your practice. We used a 5-point
Likert response category where surgeons indicated the share
of their patients who received the particular practice process
item (from none or very few to almost all). Scale scores were
calculated by summing items and dividing the resulting score
into 3 categories (low, moderate, and high).
Additional Variables
For the mastectomy versus BCS model, we included a
measure of surgeons’ attitudes toward recommending the 2
treatment options (mastectomy vs. BCS). Surgeons were
given a scenario describing a 60-year-old, 3 cm grade 3
infiltrating ductal carcinoma (estrogen receptor/progesterone
receptor and human epidermal receptor-2 negative) with no
contraindications to the surgery options. They were asked
which treatment they would recommend and how strongly.
We categorized the responses into those who would recom-
mend mastectomy versus BCS.
Analysis
The analytic dataset contained all respondents with
complete information for all variables used in the analyses
(except for tumor size and histologic grade where missing
observations were 6.6% and 7.8% of the sample respectively,
and were placed in a “missing” category). We had 1639
patient observations clustered within 277 surgeons (median, 6
patients; range, 1–34) for the mastectomy outcome and 597
patients who received reconstruction surgery following mas-
tectomy clustered in 217 surgeons (median, 3 patients; range,
1–20). Bivariate comparisons with the excluded observations
showed no significant differences in any of the analysis
variables. We first generated descriptive statistics for all of
the variables and examined patterns of missing variables. All
of these estimates were weighted to account for the differen-
tial probability of selection.
We used multilevel logistic regression models to esti-
mate the amount of variation at the surgeon and patient level,
and to examine the relative contribution of both patient and
surgeon variables in explaining that variation. The models for
both outcomes included the design variables (site and race/
ethnicity), other patient demographics (age, education, mar-
ital status), and breast cancer clinical characteristics. The
design variables were included in all models to account for
the differential probability of selection of subjects based on
categories of race by SEER site (Los Angeles vs. Detroit)
generated by our sampling strategy (described earlier in the
text). The clinical contraindication to BCS variables was
tested next for the mastectomy model.
We then added the surgeon level variables. We first
tested bivariate relationships. We then added all the variables
that were significant at a 0.10 level in the dichotomous
relationships to the model and eliminated them if the likeli-
hood ratio test was not significant when comparing the nested
models.
Finally, we tested for the presence of a cross-level
interaction between individual surgeon and patient char-
acteristics for geographic site, those variables with a large
effect on the outcome, or those for which we hypothesized
that the coefficient of that effect might vary across sur-
geons. For the mastectomy model, we tested the heteroge-
neity of the education and contraindication to BCS vari-
able across surgeons by testing whether the coefficient was
random at the surgeon level. For the reconstruction model,
we tested the heterogeneity of the coefficient for education
across individual surgeon.
For each model, we calculated several measures that
describe the amount of surgeon variation in the rates of
mastectomy and reconstruction. These include the proportion
of variation explained by the patient covariates and the
residual surgeon level variation quantified using the method
described by Snijders.20 This method provides an estimate of
the proportion of the variance on the log odds scale attribut-
able to the latent variable representing differences in rates
across surgeons as well as the variance explained by the
included covariates. We also provide a graphical presentation
of the direct variation in rates as a function of the surgeon
effect. All analyses were conducted using Stata software for
Windows (version 10.1; StataCorp LP, College Station, TX).
RESULTS
Treatment Receipt
Overall, one-quarter (439, 26.8%) of women in our
sample received mastectomy as initial surgical treatment. An
additional 152 (9.3%) received mastectomy after 1 or more
attempts at lumpectomy, but are counted for this analysis as
initially receiving BCS. About one-third of the women who
ultimately received mastectomy (222 of 591, 37.6%) had
received reconstruction at the time of the survey.
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Patient Characteristics
Table 1 shows patient characteristics and the distribution
of receipt of initial mastectomy and receipt of reconstruction
after mastectomy by subgroups. One-quarter had tumors 1 cm;
31.1% had tumors between 1 and 2 cm; and 39.7% had tumors
greater than 2 cm. About one-fifth had DCIS. Patient report of
clinical contraindications to BCS was uncommon. One-fifth of
patients were less than 50, and 21.2% were 65 and older. About
half of women were white, 26.6% were black, and 25.3% were
Latina. One-third of patients were high school graduates or less.
Over half were partnered. About half were from Los Angeles,
and 46.1% were from Detroit.
Surgeon Characteristics
Table 2 shows characteristics of the surgeon sample.
One-fifth were female and the mean number of years in
practice was 18.4 (standard deviation, 10.7); 61.7% were
from Los Angeles and 38.3% were from Detroit. One-third
devoted 15% or less of their practice to breast cancer and
16.8% devoted 50% or more. One-quarter indicated that their
main practice affiliation was a cancer center, with 40.1% in a
practice affiliated with an ACoS Cancer Program. One-third
of surgeons scored low on the Multidisciplinary Communi-
cation scale (31.9%) and on the Availability of Clinical
Information Scale. Two-thirds scored low on the Patient






Tumor size 0.001 0.001
10 mm 372 22.7 15.9 48.3
10–19 mm 509 31.1 19.1 36.5
20–39 mm 440 26.9 27.9 27.9
40 mm 210 12.8 47.9 34.3
Missing 108 6.6 34.0 39.9
Histologic grade 0.001 0.005
1 272 16.6 14.4 45.6
2 587 35.8 24.3 34.7
3 592 36.1 30.5 32.5
4 60 3.7 22.7 44.6
Missing 128 7.8 28.9 33.9
Tumor behavior 0.001 0.001
DCIS 330 20.1 14.4 56.3




No contraindications 1423 86.8 16.9 36.3
Contraindications 216 13.2 85.6 32.9
Age group 0.001 0.001
50 438 26.7 33.9 54.1
50–64 721 44.0 22.8 37.4
65 480 29.3 21.2 8.2
Race 0.239 0.038
Latina 505 25.3 29.8 28.1
Black 436 26.6 24.5 33.1
White 749 45.7 23.8 38.4
Other 39 2.4 25.8 22.5
Education 0.525 0.001
Higher secondary graduation or less 657 40.1 24.4 18.7
Some college or more 982 59.9 25.3 42.2
Marital status 0.703 0.001
Not married 728 44.4 25.3 25.7
Married/partner 911 55.6 24.8 41.6
SEER site 0.003 0.001
Los Angeles 884 53.9 23.9 32.0
Detroit 755 46.1 27.9 43.5
*Values are expressed as number and unweighted percentages.
†Values are expressed as weighted percentages to account for the sampling design.
‡P values test differences in distribution of receipt of treatment by subgroups.
DCIS indicates ductal carcinoma in situ.
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Decision Support scale. Only 14.9% of surgeons favored
mastectomy in the treatment scenario.
Independent Correlates of Mastectomy
Receipt of initial mastectomy was positively associated
with larger tumor size, advanced histologic grade, invasive
disease behavior, and report of clinical contraindication to
BCS (all P  0.001). No patient sociodemographic variables
or surgeon characteristics, including practice organizational
factors and surgeon attitudes toward treatment, were signifi-
cantly associated with receipt of mastectomy after controlling
for clinical factors. There were no interactions between SEER
site and other covariates.
Between-Surgeon Variation in Receipt of
Mastectomy
Table 3 summarizes the multilevel model results for the
mastectomy versus BCS outcome. Overall, the model ex-
plained 37% of the total variation in mastectomy rates with
patient clinical factors and patient report of a clinical contra-
indication to BCS the primary explanatory variables (Column
A). Variation of 7% in mastectomy versus BCS among
women in our sample was attributed to individual surgeons
after controlling for patients clinical and demographic factors
(Column B). The proportion of variation unexplained at the
surgeon level decreased to 4% when clinical contraindication
to BCS was added to the model, indicating that including this
variable reduced unexplained between-surgeon variation by
43% (Column C). Surgeon variables added sequentially to the
model did not further explain variance at the patient or
surgeon level.
Independent Correlates of Breast
Reconstruction
Receipt of breast reconstruction after mastectomy was
positively associated with smaller tumor size, noninvasive
disease, younger age, and higher education. Reconstruction
was positively associated with more multidisciplinary com-
munication (adjusted odds ratio OR, 3.7 and 3.4 for high
and moderate levels of communication vs. lowest level; Wald
test, 8.7; P  0.012). On further evaluation, we determined
that this association was entirely due to 1 item in the scale:
share of patients for whom the surgeon respondent consulted
with a plastic surgeon prior to surgery. When 1 variable
constructed from this item (1/3 or more vs. none or few
patients referred to plastic surgeon prior to surgery) was
included in a model substituting for the scale, the adjusted
OR was 6.6 (95% confidence interval, 3.2, 13.9).
We evaluated whether there were significant interac-
tions between patient and surgeon level variables. There were
no interactions between SEER site and other covariates. We
then focused on patient education, because the base model
showed that patients with lowest education were less likely to
receive reconstruction (OR, 0.45; 95% confidence interval,
0.25, 0.78), and it seemed plausible that this effect of educa-
tion might be modified by different surgeon communication
styles or abilities. Patients with low education were widely
dispersed across surgeon: 217 of 277 surgeons in the dataset
had 1 or more low-education patients in their panel, and 62
had 4 patients or more. There was no evidence that the effect
of education on reconstruction varied across surgeon (likeli-
hood ratio 2 0.0; P  0.9).





Years in practice (mean, SD) 18.4 10.7
SEER site







NCI Cancer Center 79 28.5
















*Values are expressed as number and unweighted percentages.
†Percent of total practice devoted to breast cancer.
NCI indicates National Cancer Institute; SD, standard deviation.















Contraindication to BCS 37% 4% 43%
Surgeon demographics 37% 4% 0




*N  1639 patients and 277 surgeons.
†Column A: R2 results after inclusion of patient and surgeon variable sets.
‡Column B: Percent of total variation attributable to individual surgeons.
§Column C: Percent of between-surgeon variation explained after including vari-
able sets.
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Between-Surgeon Variation in Receipt of
Reconstruction
In contrast to the results for mastectomy, the individual
surgeon explained a substantial amount of the patient varia-
tion in receipt of breast reconstruction (Table 4). Overall, the
model explained 45% of the total patient variation with
contributions from both patient and surgeon factors (Column
A). Variation (6%) in receipt of reconstruction among women
who were treated with mastectomy was attributable to indi-
vidual surgeons after controlling for patient clinical and
demographic variables (Column B). Surgeon practice factors
explained 31% of the between-surgeon variation (Column C).
The effect of surgeon practice factors on between-surgeon
variation in reconstruction was due solely to 1 item in the
multidisciplinary communication scale: surgeon’s share of
new patients in their practice for whom the surgeon talked to
a plastic surgeon prior to surgery. When this item was entered
in a model (binary variable few or no patients vs. more) with
only patient level variables, it accounted for 31% of the
between-surgeon variation in reconstruction. No other sur-
geon practice variables contributed to between-surgeon vari-
ation in reconstruction.
The Figure 1 (see the Appendix Supplement Digital
Content 1 http://links.lww.com/MLR/A99) illustrates the
surgeon effect directly on the scale of mastectomy and
reconstruction rates. The Figure 1 (Supplemental Digital
Content 1 http://links.lww.com/MLR/A99) shows the es-
timated average surgeon rate of mastectomy and breast
reconstruction for a typical patient in clinical practice
across the different individual surgeons in the sample
(indicated by the change in procedure rate moving from 1
end to the other of the surgeon distribution shown on the
x-axis). It also shows differences in procedure rates across
important clusters of clinical characteristics described in
the figure legend (shown by the difference in rates seen
between curves on each graph). Thus, the magnitude of
these absolute differences in use rates can be compared
across surgeon and by key patient characteristics.
For mastectomy, the graphs show that the magnitude of
effect of having a clinical contraindication to breast-conserv-
ing surgery dwarfs the differences in the propensity to do a
mastectomy across surgeons. However, the effect, within an
individual surgeon’s practice, when comparing the mastec-
tomy rates of a women with a smaller moderately differen-
tiated tumor to one with a larger more poorly differentiated
tumor, is similar in magnitude to going from a surgeon with
a low average rate of mastectomy to one with a high rate. For
reconstruction, the differences in rate of reconstruction across
surgeon (moving from left to right along the x-axis) are for
the most part larger than those within surgeon across clinical
characteristics (moving across curves at any given x-axis
location representing an individual surgeon).
Comment
We performed a survey of patients recently diagnosed
with breast cancer in the Los Angeles and Detroit metropol-
itan areas, and a companion survey of their attending sur-
geons to examine surgeon influences on variations in initial
receipt of mastectomy and postmastectomy reconstruction.
We found that individual surgeon explained only a modest
amount of the total variation in receipt of mastectomy (4%)
after controlling for patient clinical and sociodemographic fac-
tors, but a much greater amount of total variation in reconstruc-
tion (16%). With regard to our first study question: more precise
specification of receipt of treatment; better identification of
women with contraindications to mastectomy; and inclusion of
a more representative spectrum of breast cancer severity in
our sample did not eliminate the surgeon level variation in
rates of mastectomy and reconstruction that we had previ-
ously observed.9
Our second study question was whether practice
organizational factors would explain some of the residual
differences in mastectomy and reconstruction rates across
surgeons. Our results suggest little association between
mastectomy and these factors: Neither surgeon demo-
graphics (gender and years in practice), nor practice factors
(breast cancer specialization and patient management process
measures); nor attitudes about the treatment options measured
using scenarios further explained between-surgeon variation
in receipt of treatment. For reconstruction, 1 surgeon patient
management process factor (share of the surgeons patients for
whom the surgeon consulted with plastic surgeon prior to
surgery) explained a substantial amount of the remaining
between surgeon variation (31%).
Unique to the current analyses was the addition of
surgeon patient management process factors to these mod-
els. These measures were developed based on the Chronic
Care Model,8 which addresses basic elements for improving
care in health systems including multidisciplinary care teams,
and patient decision and care support.21,22 The model has
been applied to research addressing the patterns of treat-
ment and quality of care of patients with diabetes, heart
disease, and depression. These types of factors have been
highlighted by national organizations, including the Insti-
tute of Medicine, as potential mechanisms for improving
the quality of cancer care. Despite the interest in these
management process factors, there have been no larger
studies that have incorporated these potentially important
measures to evaluate patterns of treatment during the
initial course of therapy. However, variables designed to
measure most of the reasons that have been hypothesized



















*N  597 patients and 217 surgeons.
†Column A: R2 results after inclusion of patient and surgeon variable sets.
‡Column B: Percent total variation attributable to individual surgeons.
§Column C: Percent of between-surgeon variation explained after including vari-
able sets.
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as leading to practice variation (including surgeon experi-
ence, attitudes, and whether they practice in settings where
there are opportunities for patient decision support and
multidisciplinary input) did not further explain between-
surgeon variation in treatment.
Strengths of the study included a large diverse sam-
ple of patients in 2 urban regions of the United States. We
were able to link over 98% of respondent patients to an
attending surgeon and nearly 75% of surgeons completed
a survey. We collected a comprehensive set of surgeon
level variables including demographics; level of special-
ization in breast cancer; and measures of surgeon patient
management factors. However, our findings should be
interpreted in the context of some limitations. The fact that
our surveys were conducted in 2 large, urban geographic
locations (Detroit and Los Angeles) limits the generaliz-
ability, particularly to more rural locations. We had limited
power to detect small socioeconomic status gradients in
use of reconstruction because of the sample size and thus
these results should be interpreted with some caution.
Nonresponse and nonmatching between some patients and
surgeons may have also limited generalizability of our
findings, particularly for surgeons with very low patient
volumes. We were unable to account for the potential
clustering of surgeons within practices or hospitals. How-
ever, the procedures we studied in this are commonly done
by many general surgeons and one surgeon may practice at
different hospital locations, lessening any potential impact
of hospital-related clustering. We were also limited by the
self-reported nature of some variables on both the patient
and surgeon side.
Implications
Our findings have important implications for health
policy. Lingering concerns about overtreatment with mas-
tectomy at the hands of surgeons have diminished in
response to recent research suggesting that surgeons’ rec-
ommendations for treatment are generally appropriate, and
that patient preferences play an important role in decision-
making.2,4 The very modest effect of individual surgeon on
variation in mastectomy use observed in this study rein-
forces the notion that surgeons have largely adopted a
uniform approach to the initial surgery options. Further-
more, between-surgeon variation in receipt of mastectomy
was not attributable to surgeon demographics or patient
management processes related to a more coordinated can-
cer care approach to treatment. Although these practice
management factors may be desirable for other reasons,
they do not seem to explain differences in the surgical
treatment options that women receive.
By contrast, the wide between-surgeon variation in
receipt of breast reconstruction after mastectomy suggests
that patients should be more cautious about how these
decisions are made in clinical practice. In particular, the
very strong effect of exposure to plastic surgeons prior to
decisions about local therapy suggests that 1 possible
result of multidisciplinary models of decision-making may
be a much greater likelihood of receiving breast recon-
struction after mastectomy. Prior literature suggests that
patient satisfaction and quality of life related to breast
reconstruction are high. But some patients who do not get
it report lack of information or difficulties finding a sur-
geon who will perform it despite state laws that mandate
insurance coverage.6,7 Our findings suggest that the treat-
ment decision context and access to breast reconstruction
vary across surgeon practices.
Our findings may inform interventions to reduce SES
disparities in receipt of breast reconstruction after mastec-
tomy. Similar to another study, we observed large socioeco-
nomic disparities in the receipt of breast reconstruction after
mastectomy.6 A key question is whether the SES gradient in
receipt of reconstruction varied across surgeon (reflecting a
differential ability to bridge this disparity on the part of
individual surgeons). We did not find any evidence of the
heterogeneity of this effect. These findings suggest that in-
terventions to reduce these disparities should be targeted
broadly across the surgeon community.
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